The annual revenue for Hologic for 2023 in perinatal was $127MillionUSD (rounded) which had a growth of around 9% on the previous year. That segment includes FFN testing.
Worth noting, their entire perinatal and cytology segment was $485Million (rounded) for the same year. Cytology is also diagnostics for prenatal diagnosis and infectious disease detection.
I would hazard a guess that the market we could be looking at for LDX within Hologic is the $485Million.
Not out of the realm that revenues could be the size you reckon if we can access the higher segment.
The annual revenue for Hologic for 2023 in perinatal was...
Add to My Watchlist
What is My Watchlist?
